|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| A61K 38/20 | |||
| A61P 35/00 | |||
| C07K 16/24 |
| (11) | Number of the document | 2608808 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11820492.4 |
| Date of filing the European patent application | 2011-08-23 | |
| (97) | Date of publication of the European application | 2013-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/048747 |
| Date | 2011-08-23 |
| (87) | Number | WO 2012/027324 |
| Date | 2012-03-01 |
| (30) | Number | Date | Country code |
| 201161480635 P | 2011-04-29 | US | |
| 376097 P | 2010-08-23 | US | |
| 411183 P | 2010-11-08 | US | |
| 406759 P | 2010-10-26 | US |
| (72) |
SIMARD, John, US
|
| (73) |
XBiotech, Inc,
1055 West Hastings Street, Suite 300, Vancouver, BC V6E 2E9,
CA
|
| (54) | TREATMENT FOR NEOPLASTIC DISEASES |
| TREATMENT FOR NEOPLASTIC DISEASES |